21 May 2013
Keywords: biogen, idec, avonex, launched, japan, usa-based, drug
Article | 20 November 2006
USA-based drug developer Biogen Idec says that its multiple sclerosis therapy Avonex (Interferon beta 1a) is now available in Japan. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.